Rare variant burden testing failed to identify an association with any gene; however, it did show a nominally significant link with ERN1 and TRPC3. This study provides evidence to support a genetic overlap between CSVD and Alzheimer’s disease. This evidence concerns the gene TRPC3 and early-onset autosomal dominant Alzheimer disease.